RK

Ronald Knegtel

VI Vertex Pharmaceuticals Incorporated: 2 patents #28 of 235Top 15%
Merck: 1 patents #198 of 681Top 30%
Overall (2024): #123,248 of 561,600Top 25%
2
Patents 2024

Issued Patents 2024

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
12084438 GCN2 inhibitors and uses thereof Matthew Bleich, Jean-Damien Charrier, Huijun Dong, Steven Durrant, Meredith Suzanne Eno +11 more 2024-09-10
11919887 Substituted tetrahydrofurans as modulators of sodium channels Steven Durrant, Nadia Ahmad, Elizabeth Mary Beck, Lidio Marx Carvalho Meireles, Ewa Iwona Chudyk +15 more 2024-03-05